We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

School Response to Families Who Have Children With Cancer

This study has been withdrawn prior to enrollment.
(Business decision)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01148082
First Posted: June 22, 2010
Last Update Posted: June 26, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Stanford University
  Purpose
The purpose of this research is to investigate school response to families who have children with cancer. It is anticipated that the results of this study will enhance the support that schools can give to the population of families who have a child with cancer. The study will involve the parents in these families, the principal and an educator in the school of the child with cancer. Measurement tools will include surveys, interviews, and other relevant educational and medical documents.

Condition Intervention
Carcinomas Squamous Cell Carcinoma Adenocarcinoma Procedure: Self administered Surveys Procedure: Interviews

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: School Response to Families Who Have Children With Cancer

Further study details as provided by Stanford University:

Primary Outcome Measures:
  • Evidence of support [ Time Frame: one time ]
    Identify significant patterns. Documents, interview, surveys and the quantitative instrument will be analyzed with an inductive cross-case analysis. Inductive analysis means that the patterns, themes, and categories emerged out of the data rather than being imposed on them prior to data collection and analysis. A cross-case analysis means that the information will be grouped together according to answers from different people, themes, perspectives or issues. Then, a content analysis will be conducted which includes the process of identifying, coding, and categorizing the primary patterns in the data. In the final step, the data will be interpreted. Interpretation, by definition, goes beyond description. Interpretation means attaching significance to what was found offering explanations, drawing conclusions, making inferences, building linkages, attaching meaning, imposing order and dealing with rival explanations


Enrollment: 0
Anticipated Study Start Date: September 2010
Estimated Study Completion Date: July 2011
Estimated Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Prospective participants will be parents/caregivers who have had school-age children treated for cancer within the last 5 years
Criteria

Inclusion Criteria:

  • Patients will not be recruited. Only parents, the school principals and the teachers will be recruited.
  • Subjects will be 15 sets of parents who have had school-age children treated for cancer within the last 5 years.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01148082


Locations
United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Michael Link Stanford University
  More Information

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT01148082     History of Changes
Other Study ID Numbers: PEDSVAR0010
SU-09112009-3880 ( Other Identifier: Stanford University )
17105 ( Other Identifier: Stanford IRB )
First Submitted: June 18, 2010
First Posted: June 22, 2010
Last Update Posted: June 26, 2017
Last Verified: June 2017

Keywords provided by Stanford University:
Carcinomas (including Squamous Cell and Adenocarcinoma)

Additional relevant MeSH terms:
Carcinoma
Carcinoma, Squamous Cell
Adenocarcinoma
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Squamous Cell